Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Nivolumab
Related studies linked through entity extraction aliases.
A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United Kingdom
- Status
- COMPLETED
- Phase
- N/A
Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
- Status
- RECRUITING
- Phase
- PHASE2
NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative
- Status
- SUSPENDED
- Phase
- PHASE2/PHASE3
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of XB002 in Subjects With Solid Tumors (JEWEL-101)
- Status
- COMPLETED
- Phase
- PHASE1
Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML
- Status
- RECRUITING
- Phase
- PHASE2
REduced Frequency ImmuNE Checkpoint Inhibition in Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
- Status
- RECRUITING
- Phase
- PHASE2
Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)
- Status
- COMPLETED
- Phase
- PHASE2
Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
- Status
- RECRUITING
- Phase
- PHASE1
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
- Status
- TERMINATED
- Phase
- PHASE2
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)
- Status
- COMPLETED
- Phase
- PHASE2
CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1